Reuters logo
BRIEF-Aevi Genomic Medicine Q3 loss per share $0.23
November 2, 2017 / 1:40 PM / 23 days ago

BRIEF-Aevi Genomic Medicine Q3 loss per share $0.23

Nov 2 (Reuters) - Aevi Genomic Medicine Inc:

* Aevi Genomic Medicine reports third quarter 2017 financial results

* Q3 loss per share $0.23

* Q3 earnings per share view $-0.22 -- Thomson Reuters I/B/E/S

* Aevi Genomic Medicine Inc - ‍company had cash and cash equivalents of $14.96 million at September 30, 2017​

* Aevi Genomic Medicine Inc- ‍expects current cash balance, including proceeds from pipe offering, to fund operations into early 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below